Mary L. Smith
Director, PTC Therapeutics.
Companies
- PTC TherapeuticsBoard member Jun 15, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
PTC Therapeutics PTCT21,813 shares2$1.3M at $60.99Jul 9, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 9, 2026Sold 5,834 shares at $90.00 of PTC Therapeutics2
- Jul 9, 2026Exercised options 5,834 shares at $42.95 of PTC Therapeutics2
- Jul 9, 2026Sold 10,000 shares at $90.00 of PTC Therapeutics2
- Jul 9, 2026Exercised options 10,000 shares at $42.95 of PTC Therapeutics2
- Jan 2, 2026Granted 4,000 shares of PTC Therapeutics3
- Jan 3, 2025Granted 4,000 shares of PTC Therapeutics4
- Feb 15, 2024Granted 4,000 shares of PTC Therapeutics5
- Jan 5, 2023Granted 4,000 shares of PTC Therapeutics6
- Jan 7, 2022Granted 3,200 shares of PTC Therapeutics7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPTC Therapeutics, Board member
- 2
- 3SEC EDGARForm 4 filed Jan 6, 2026
- 4SEC EDGARForm 4 filed Jan 7, 2025
- 5SEC EDGARForm 4 filed Feb 16, 2024
- 6SEC EDGARForm 4 filed Jan 9, 2023
- 7SEC EDGARForm 4 filed Jan 11, 2022